CVE-2022-36634

CVE-2022-36634 is a high-severity vulnerability in Zkteco Zkbiosecurity V5000 with a CVSS 3.x base score of 8.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-863.

Key facts

Description

An access control issue in ZKTeco ZKBioSecurity V5000 3.0.5_r allows attackers to arbitrarily create admin users via a crafted HTTP request.

Frequently asked questions

What is CVE-2022-36634?
An access control issue in ZKTeco ZKBioSecurity V5000 3.0.5_r allows attackers to arbitrarily create admin users via a crafted HTTP request.
How severe is CVE-2022-36634?
CVE-2022-36634 has a CVSS 3.x base score of 8.8, rated high severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2022-36634 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (68th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2022-36634?
CVE-2022-36634 affects Zkteco Zkbiosecurity V5000. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2022-36634?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2022-36634 published?
CVE-2022-36634 was published on 2022-10-07 and last updated on 2026-07-05.

References

Affected products (1)

More vulnerabilities in Zkteco Zkbiosecurity V5000

All CVEs affecting Zkteco Zkbiosecurity V5000 →

Other CWE-863 (Incorrect Authorization) vulnerabilities

Browse all CWE-863 (Incorrect Authorization) vulnerabilities →